144 related articles for article (PubMed ID: 2917110)
1. Studies on morphine disposition: influence of general anaesthesia on plasma concentrations of morphine and its metabolites.
Sear JW; Hand CW; Moore RA; McQuay HJ
Br J Anaesth; 1989 Jan; 62(1):22-7. PubMed ID: 2917110
[TBL] [Abstract][Full Text] [Related]
2. Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites.
Sear JW; Hand CW; Moore RA; McQuay HJ
Br J Anaesth; 1989 Jan; 62(1):28-32. PubMed ID: 2644963
[TBL] [Abstract][Full Text] [Related]
3. Studies on morphine disposition: plasma concentrations of morphine and its metabolites in anesthetized middle-aged and elderly surgical patients.
Sear JW; Hand CW; Moore RA
J Clin Anesth; 1989; 1(3):164-9. PubMed ID: 2627383
[TBL] [Abstract][Full Text] [Related]
4. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
8. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.
Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH
Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170
[TBL] [Abstract][Full Text] [Related]
9. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
[TBL] [Abstract][Full Text] [Related]
10. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
[TBL] [Abstract][Full Text] [Related]
11. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
13. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
[TBL] [Abstract][Full Text] [Related]
14. Oral morphine in cancer pain: influences on morphine and metabolite concentration.
McQuay HJ; Carroll D; Faura CC; Gavaghan DJ; Hand CW; Moore RA
Clin Pharmacol Ther; 1990 Sep; 48(3):236-44. PubMed ID: 2401122
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
[TBL] [Abstract][Full Text] [Related]
16. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma.
Chapman DJ; Joel SP; Aherne GW
J Pharm Biomed Anal; 1994 Mar; 12(3):353-60. PubMed ID: 8031935
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.
Goucke RC; Hackett PL; Ilett KF
Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
